ArticleACS sustainable chemistry & engineering2026
Immobilized Hydroxymethylfurfural Oxidase Enables Robust Biocatalytic Production of 2,5-Furandicarboxylic Acid from Crude 5‑Hydroxymethylfurfural.
Article in ACS sustainable chemistry & engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bioplastics such as poly-(ethylene 2,5-furandicarboxylate) (PEF), synthesized from biobased 2,5-furandicarboxylic acid (FDCA), offer a promising alternative to petrochemical-derived plastics. Enzymatic conversion of 5-hydroxymethylfurfural (HMF) to FDCA via hydroxymethylfurfural oxidase (HMFO) is environmentally benign but is limited by catalyst stability. This study addresses these challenges through a high-performance biocatalytic platform based on the one-step purification and immobilization of the engineered enzyme 8BxHMFO fused with a carbohydrate-binding module (CBM3). Utilizing the high affinity of CBM3 for microcrystalline cellulose (Perloza MT100), the biocatalyst achieved a significant increase in thermal stability (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.